NCT03877991View on ClinicalTrials.gov

Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

February 19, 2025

Study Completion Date

February 19, 2025

Conditions
Pain
Interventions
DRUG

CBD-sesame oil capsule

A capsule containing cannabidiol dissolved in sesame oil and surfactant vehicle.

DRUG

CBD-LNL capsule

A capsule containing Cannabidiol dissolved in self nano emulsifying formulation

DRUG

CBD powder form capsule

Powder of Cannabidiol filled in a hard gelatin capsule, without formulation.

Trial Locations (1)

9112001

RECRUITING

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER